2003, Drug Pricing and Pharmaceutical Companies

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2003

Drug Pricing

Pharmaceutical Companies

STAT+: Pharmalittle: Next big hope for Alzheimer’s might not help most Black patients; drugmakers ask Supreme Court to toss terrorism-support ruling

STAT

JULY 6, 2023

Advertisements eviscerating and glorifying pharmacy benefit managers have been around for years, but have intensified over the past three months as Congress scrutinizes the role these middlemen play in shaping high prescription drug prices , STAT tells us.

Drug Pricing

Drug Pricing Vaccines Diabetes Pharmaceutical Companies

The Issue with Reissue: PTE Edition

FDA Law Blog: Biosimilars

MARCH 18, 2025

Even though the PTE provisions established in the Drug Price Competition and Patent Restoration Act are forty-plus years old, courts are still grappling with questions about how to best implement the Patent Term Extension. The Court thus explained that interpreting the patent in 35 U.S.C.

Drug Pricing

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies

Pharmacist Digest

STAT+: Pharmalittle: Next big hope for Alzheimer’s might not help most Black patients; drugmakers ask Supreme Court to toss terrorism-support ruling

The Issue with Reissue: PTE Edition

Stay Connected